RISK FACTORS OF DEVELOPING STEM CELL THERAPY IN PATIENTS WITH NEUROLOGICAL DISORDERS
Основное содержимое статьи
Аннотация
Neurodegenerative diseases are global health issues associated with inadequate therapeutic options and an inability to restore the damaged neural system. Stem cell therapy holds promise for treating degenerative diseases and cancer and repairing damaged tissues, for which there are currently no or limited therapeutic options. Despite the clinical potential of stem cell-based medicinal products, there are also potential and unanticipated risks. These risks deserve thorough discussion from the perspective of current scientific knowledge and experience. The identified risks (i.e., risks identified in clinical experience) or potential/theoretical risks (i.e., risks observed in animal studies) include tumor formation, unwanted immune responses, and the transmission of adventitious agents. Currently, there is no clinical experience with pluripotent stem cells (i.e., embryonal stem cells). Methods. A review of the literature on the risk factors for stem cells in neurological disorders revealed that tumor suppressors could be used in patients, and we could perform in vitro examinations before administering stem cells to patients to reduce the immune rejection ratio. Conclusion. The amount of data and the knowledge of the risks associated with the use of stem cell therapy are expanding. The perceived risk of tumor formation is greater for induced pluripotent neuronal stem cells (iPSCs) than for embryonic stem cells (ESCs). However, the mechanism of action of stem cell therapy is still unclear.
Информация о статье
Библиографические ссылки
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011). Risk factors in the development of stem cell therapy. Journal of translational medicine, 9, 1-14.
Kim, S. U., & De Vellis, J. (2009). Stem cell‐based cell therapy in neurological diseases: a review. Journal of neuroscience research, 87(10), 2183-2200.
Lodi, D., Iannitti, T., & Palmieri, B. (2011). Stem cells in clinical practice: applications and warnings. Journal of Experimental & Clinical Cancer Research, 30(1), 1-20.
Lindvall, O., Kokaia, Z., & Martinez-Serrano, A. (2004). Stem cell therapy for human neurodegenerative disorders–how to make it work. Nature medicine, 10(Suppl 7), S42-S50.
Hejrati, N., Wong, R., Khazaei, M., & Fehlings, M. G. (2023). How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome. Expert Opinion on Biological Therapy, 23(9), 883-899.
Stoddard-Bennett, T., & Pera, R. R. (2020). Stem cell therapy for Parkinson’s disease: safety and modelling. Neural Regeneration Research, 15(1), 36.
Barker, R. A., Jain, M., Armstrong, R. J. E., & Caldwell, M. A. (2003). Stem cells and neurological disease. Journal of Neurology, Neurosurgery & Psychiatry, 74(5), 553-557.
Giyosovna, S. D., Fazliddinovna, B. M., & Muzaffar Giyos og, A. (2023). IDENTIFICATION AND ISOLATION OF ENDOPHYTIC FUNGI PRODUCING L-ASPARAGINASE IN REPRESENTATIVES OF THE ASTERATCEA FAMILY. Science and Innovation, 2(2), 107-112.
Wertz, D. C. (2002). Embryo and stem cell research in the United States: history and politics. Gene therapy, 9(11), 674-678.
Rueger, M. A., & Schroeter, M. (2015). In vivo imaging of endogenous neural stem cells in the adult brain. World Journal of Stem Cells, 7(1), 75.
Zhao, L., Liu, J. W., Shi, H. Y., & Ma, Y. M. (2021). Neural stem cell therapy for brain disease. World journal of stem cells, 13(9), 1278–1292. https://doi.org/10.4252/wjsc.v13.i9.1278
Choi, D. H., Kim, J. H., Kim, S. M., Kang, K., Han, D. W., & Lee, J. (2017). Therapeutic potential of induced neural stem cells for Parkinson’s disease. International journal of molecular sciences, 18(1), 224.
Viswaprasad, A., & Annaev, M. (2023). BRONCHIAL ASTHMA: CURRENT CONCEPTS. Interpretation and researches, 1(10).
Gulnora, A., Muzaffar, A., Atithi, K., & Deshpande, A. S. (2023). IMPACT OF METABOLIC SYNDROME ON COVID-19 AND CORONARY ARTERY DISEASE: CLINICAL AND PATHOGENETIC INSIGHTS. Science and innovation, 2(Special Issue 8), 379-386.
Chettiam, S., Maffi, J. V., Alexander, D., Joseph, J., & Annaev, M. (2023). NEW FINDINGS AND PATHOLOGICAL ASPECTS OF PNEUMONIA. Interpretation and researches, 1(9).